Skip to content
10-Q

Quarterly Report

BIODESIX INC BDSX

0001193125-25-262532

← back to feed
Filed
Nov 3, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 28, 2025 7.96M sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.5M sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.38M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 7.32M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 6.18M sh
Capex Q3 2025 · Sep 30, 2025 $173K
Capex Q3 2025 · Sep 30, 2024 $2.39M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$24.05M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$44.55M
Long Term Debt Q3 2025 · Sep 30, 2025 $50.01M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $16.6M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $26.25M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$1.72M
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.14M
Stockholders Equity Q3 2025 · Mar 31, 2025 $11.06M
Stockholders Equity Q3 2025 · Dec 31, 2024 $20.88M
Stockholders Equity Q3 2025 · Sep 30, 2024 $27.86M
Stockholders Equity Q3 2025 · Jun 30, 2024 $36.26M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$5.5M
Stockholders Equity Q3 2025 · Dec 31, 2023 $4.58M
Current Liabilities Q3 2025 · Sep 30, 2025 $18.15M
Current Liabilities Q3 2025 · Dec 31, 2024 $14.32M
Total Liabilities Q3 2025 · Sep 30, 2025 $90.44M
Total Liabilities Q3 2025 · Dec 31, 2024 $76.37M
Current Assets Q3 2025 · Sep 30, 2025 $33.4M
Current Assets Q3 2025 · Dec 31, 2024 $39.48M
Total Assets Q3 2025 · Sep 30, 2025 $88.72M
Total Assets Q3 2025 · Dec 31, 2024 $97.24M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.16
Eps Diluted Q3 2025 · Sep 30, 2025 −$4.24
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$1.40
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$5.61
Eps Basic Q3 2025 · Sep 30, 2025 −$1.16
Eps Basic Q3 2025 · Sep 30, 2025 −$4.24
Eps Basic restated Q3 2025 · Sep 30, 2024 −$1.40
Eps Basic restated Q3 2025 · Sep 30, 2024 −$5.61
Sga Expense Q3 2025 · Sep 30, 2025 $21.71M
Sga Expense Q3 2025 · Sep 30, 2025 $64.57M
Sga Expense Q3 2025 · Sep 30, 2024 $20.02M
Sga Expense Q3 2025 · Sep 30, 2024 $60.23M
Rd Expense Q3 2025 · Sep 30, 2025 $2.99M
Rd Expense Q3 2025 · Sep 30, 2025 $9.13M
Rd Expense Q3 2025 · Sep 30, 2024 $2.55M
Rd Expense Q3 2025 · Sep 30, 2024 $7.15M
Net Income Q3 2025 · Sep 30, 2025 −$8.72M
Net Income Q3 2025 · Sep 30, 2025 −$31.29M
Net Income Q3 2025 · Jun 30, 2025 −$11.47M
Net Income Q3 2025 · Mar 31, 2025 −$11.1M
Net Income Q3 2025 · Sep 30, 2024 −$10.26M
Net Income Q3 2025 · Sep 30, 2024 −$34.68M
Net Income Q3 2025 · Jun 30, 2024 −$10.81M
Net Income Q3 2025 · Mar 31, 2024 −$13.61M
Operating Income Q3 2025 · Sep 30, 2025 −$7.05M
Operating Income Q3 2025 · Sep 30, 2025 −$25.91M
Operating Income Q3 2025 · Sep 30, 2024 −$8.59M
Operating Income Q3 2025 · Sep 30, 2024 −$27.85M
Revenue Q3 2025 · Sep 30, 2025 $21.77M
Revenue Q3 2025 · Sep 30, 2025 $59.74M
Revenue Q3 2025 · Sep 30, 2024 $18.15M
Revenue Q3 2025 · Sep 30, 2024 $50.89M